000 | 01527 a2200433 4500 | ||
---|---|---|---|
005 | 20250516194428.0 | ||
264 | 0 | _c20141205 | |
008 | 201412s 0 0 eng d | ||
022 | _a1757-4684 | ||
024 | 7 |
_a10.1002/emmm.201303214 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLarrayoz, Marta | |
245 | 0 | 0 |
_aContrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. _h[electronic resource] |
260 |
_bEMBO molecular medicine _c04 2014 |
||
300 |
_a539-50 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
650 | 0 | 4 | _aSunitinib |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aPio, Ruben | |
700 | 1 | _aPajares, MarĂa J | |
700 | 1 | _aZudaire, Isabel | |
700 | 1 | _aAjona, Daniel | |
700 | 1 | _aCasanovas, Oriol | |
700 | 1 | _aMontuenga, Luis M | |
700 | 1 | _aAgorreta, Jackeline | |
773 | 0 |
_tEMBO molecular medicine _gvol. 6 _gno. 4 _gp. 539-50 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/emmm.201303214 _zAvailable from publisher's website |
999 |
_c23520218 _d23520218 |